I n response to exercise or other stresses, catecholamines are released into the circulation and within the heart. Catecholaminergic stimulation of ␤1-adrenergic receptors (␤1ARs) in the heart increases heart rate (chronotropy) and contractility (inotropy), resulting in increased cardiac output during acute stress. Concurrent stimulation of ␤2-ARs dilates blood vessels, which increase blood flow to exercising muscles, thereby matching increased cardiac output to metabolic demands of the organs.
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The inotropic mechanisms investigated by Valdivia and colleagues 1 in the current issue of Circulation Research are essential for the acute stress-dependent increase of cardiac output. Each of the millions of muscle cells in the heart (cardiomyocytes) contribute to myocardial force development. Cardiomyocyte contraction is controlled by intracellular Ca 2ϩ release through a process called excitationcontraction coupling (ECC) that involves the following steps: (1) an action potential (AP) depolarizes the cell membrane;
(2) voltage-dependent plasma membrane L-type calcium channels (Ca v 1.2) opening results in a whole-cell inward Ca 2ϩ current (I Ca ); (3) I Ca activates cardiac ryanodine receptor (RyR2)/Ca 2ϩ release channels located on the junctional sarcoplasmic reticulum (jSR), a process referred to as Ca 2ϩinduced Ca 2ϩ release (CICR); (4) Ca 2ϩ binds to troponin C (TnC) leading to cross-bridge formation between myosin and actin and contraction of the sarcomere. Cardiomyocyte relaxation is signaled by a return of intracellular [Ca 2ϩ ] to resting levels attributable to the following major mechanisms: (1) Ca v 1.2 inactivation; (2) RyR2 inactivation; (3) Ca 2ϩ reuptake into the SR by SERCA2a pumps; and (4) Na ϩ /Ca 2ϩ exchange extrusion of Ca 2ϩ to the extracellular space. Under resting conditions, net SR Ca 2ϩ release contributes approximately 66% of Ca 2ϩ necessary for myofilament activation in large mammals including humans, and approximately 90% in rodents. 2 Stimulation of ␤-ARs in the heart results in cAMPmediated activation of protein kinase A (PKA), which phosphorylates multiple intracellular proteins including Ca v 1.2, 3 RyR2, 4 and the SERCA2a inhibitor phospholamban (PLB). 5 PLB phosphorylation at Ser16 by PKA dissociates PLB from SERCA2a and increases SR calcium uptake. 5 Ca v 1.2 ␣-subunit phosphorylation at Ser1928 increases I Ca amplitude and shifts activation threshold to more negative voltages. 6 Using intact hearts or cardiomyocytes, multiple studies have found that RyR2 is phosphorylated by PKA during ␤-AR stimulation, [7] [8] [9] [10] [11] [12] [13] [14] [15] and that PKA phosphorylation increases the single-channel open probability. 4,7,8,16 -18 As RyR2 mediates CICR, these observations suggest that PKA-mediated RyR2 phosphorylation may directly contribute to increased cardiac function during ␤-adrenergic stimulation (ie, during stress). Despite much evidence, the fundamental question of whether RyR2 PKA phosphorylation by itself increases SR Ca 2ϩ release independent from I Ca and SR Ca 2ϩ load has been the subject of ongoing debate.
Characterizing the RyR2-specific component of SR Ca 2ϩ release in intact cells during ␤-adrenergic stimulation has been a major challenge. Both SR Ca 2ϩ load and I Ca have been recognized as important mediators of SR Ca 2ϩ release during inotropic modulation. I Ca and [Ca 2ϩ ] i can be directly measured with patch-clamp and fluorescence indicators, respectively. Therefore activation of RyR2 during CICR in intact cells has been assessed by measuring intracellular Ca 2ϩ release as a function of voltage-dependent I Ca . 19, 20 Thus, the "normalized" increase of [Ca 2ϩ ] i /I Ca , referred to as ECC "gain", can be used to dissect the catecholamine-dependent role of RyR2 in CICR.
Previously, isolation of PKA effects on RyR2 function has been addressed indirectly using pharmacological modulators and [Ca 2ϩ ] SR loading protocols in cardiomyocytes. For example, using micromolar caffeine application in paced cardiomyocytes, Eisner and colleagues observed that the amplitude of intracellular [Ca 2ϩ ] i release increased only transiently leading them to conclude that RyR2 modulation has no maintained effect on CICR gain. 21 Bers and colleagues reported that catecholamine stimulation failed to increase the CICR gain in cells examined under conditions of pacingcontrolled SR load and I Ca . 22 However, they did note that the maximal rate of CICR was significantly faster during ␤-AR stimulation indicating potentially important functional effects of RyR2 PKA phosphorylation. 22 Lederer and colleagues showed that PLB KO cardiomyocytes had increased SERCA2a activity and displayed constitutively increased SR Ca 2ϩ load and CICR gain indicating modulation of RyR2 and inotropic function by SR Ca 2ϩ load. 23 Bers and colleagues have used saponin-permeabilized PLB KO cardiomyocytes and found that cAMP could not increase Ca 2ϩ spark rate (however they performed their experiments at subphysiological Ca 2ϩ concentrations, conditions under which the RyR2 channels are known to be tightly closed), which was interpreted as evidence against a role of RyR2 for inotropic modulation. 24 In contrast, Lindegger and Niggli studied subcellular mechanisms of CICR using 2-photon limited flash-photolysis of caged Ca 2ϩ and convincingly demonstrated that independent from I Ca and SR Ca 2ϩ load, an increase in CICR occurs during ␤-AR stimulation. 25 Their results provide support for a role of RyR2 PKA phosphorylation as a mechanism of increasing ECC gain.
Significance of RyR2 PKA Phosphorylation in the Development of SR Ca 2؉ Leak During Heart Disease
Defective intracellular Ca 2ϩ homeostasis has been reported in heart failure (HF). Depressed SR Ca 2ϩ uptake, storage, or release have all been documented in HF. 26 -28 SR Ca 2ϩ load may be decreased because of depressed SERCA2a function or increased Ca 2ϩ extrusion by increased Na ϩ /Ca 2ϩ exchanger function contributing to reduced SR Ca 2ϩ load. 29, 30 Moreover, increased diastolic SR Ca 2ϩ leak and decreased SR Ca 2ϩ load have been directly documented in HF models. 31, 32 We 4, 9, 33 and others 34 -36 have previously demonstrated that chronic sympathetic hyperactivity in HF leads to increased protein kinase A (PKA) phosphorylation of RyR2 at Ser2808 and in decreased binding of the channel-stabilizing subunit calsta-bin2 (FKBP12.6). We have proposed that the depletion of calstabin2 from the RyR2 channel complex and PKA hyperphosphorylation of the channel results in a diastolic SR Ca 2ϩ leak and contributes to HF progression, in part by contributing to SR Ca 2ϩ depletion that impairs contractility. 4 In agreement with this "leak hypothesis", treatment with ␤-adrenergic blockers, which improve cardiac function and mortality in HF, prevents chronically increased RyR2 PKA phosphorylation, indirectly restores calstabin2 binding to RyR2, and reduces RyR2 channel leak. 33, 36 To further investigate the specific role of PKA phosphorylation of RyR2-Ser2808 in HF progression, we generated an RyR2-S2808A knock-in model resulting in mice with RyR2 channels that cannot be PKA phosphorylated. 37, 38 We induced HF in these mice by ligating the left-anterior descending artery (LAD) and showed that the RyR2-S2808A knock-in protects against HF progression, providing support for the "leak" hypothesis that chronic PKA hyperphosphorylation of RyR2 causes a diastolic SR Ca 2ϩ leak that contributes to SR Ca 2ϩ depletion and impaired contractility that underlies HF progression. 37, 38 Benkusky et al generated a similar knock-in mouse to test our hypothesis that PKA phosphorylation of RyR2-S2808 is an important determinant of HF progression. 1 However, instead of testing their mice using the post-MI HF model that we used, Benkusky et al used a model of cardiac hypertrophy induced by aortic banding. Unfortunately, the mice studied by Benkusky et al did not have HF, as evidenced by the lack of LV dilatation and the relatively preserved LV function in all groups (supplemental Table I , available online at http://circres. ahajournals.org). Indeed, 4 weeks of aortic banding resulted in intermediate cardiac hypertrophy as evidenced by histology, and echocardiography showed normal function ( Figure  1 ). After 11 weeks of banding, even though there was no evidence of heart failure per se, fractional shortening (FS) in WT banded animals was decreased by 19.2% (52.1Ϯ3.2% versus 42.1Ϯ1.2%, respectively; PϽ0.05). However, 11 weeks after banding there was no decrease in FS in the RyR2-S2808A mice (FSϭ51.0Ϯ2.6% before banding versus 51.9Ϯ5.1% in banded RyR2-S2808A mice at 11 weeks). Thus, the RyR2-S2808A mice were protected against the mild decrease in cardiac function observed in the WT mice (supplemental Table 1 ). Therefore, despite the title of their article, the Benkusky et al data do not support the authors' conclusion that HF progression is unmodified in the RyR2-S2808A mice.
Physiological Role RyR2 Modulation by Catecholamines
Benkusky et al also used the RyR2-S2808A knock-in mouse to study the role of PKA phosphorylation of RyR2 in regulating cardiac contractile function after ␤-adrenergic stimulation. We have previously identified RyR2-Ser2808 as the functionally important PKA site in RyR2. We showed that Ala for Ser substitution at Ser2808 resulted in ablation of PKA modulation of RyR2 channel function. 4, 7, 38 We further showed that hearts from our global RyR2-S2808A knock-in mice are not different from age-and litter-matched WT control hearts in terms of baseline cardiac structure and function, a prerequisite for comparing modulation of cardiac function by catecholamines between groups. 38 Benkusky et al used saponin-permeabilized RyR2-S2808A cells to characterize ECC and found no significant differences in cAMP-stimulated spontaneous SR Ca 2ϩ release events. Although these results are in agreement with Bers and colleagues using a similar approach, 24 it is important to confirm these results using intact cells with preserved subcellular membrane microdomain structures and intact signaling pathways.
Lehnart and Marks Ryanodine Receptors and Cardiac Contractility
Benkusky et al further attempted to directly test the effects of PKA phosphorylation on single RyR2-S2808A channels in lipid bilayers. They concluded that "RyR2 fails to modify its activity in response to PKA phosphorylation at diastolic Ca 2ϩ ", an expected finding because WT RyR2 channel open probability cannot be significantly increased under conditions that simulate diastole (eg, nanomolar cytosolic [Ca 2ϩ ] and millimolar cytosolic [Mg 2ϩ ]), even when the channel is PKA phosphorylated. This has to be the case otherwise there would be a Ca 2ϩ leak via RyR2 channels during routine exercise and this would have adverse consequences, eg, diastolic SR Ca 2ϩ leak can induce arrhythmias. Indeed, the inability of PKA phosphorylated WT channels to be significantly activated under diastolic conditions explains why people with normal hearts do not experience sudden cardiac death when they run or are otherwise stressed! In addition to identifying RyR2-Ser2808 as the major PKA phosphorylation site on the channel, we previously demonstrated its functional importance using single-channel measurements of recombinant and native RyR2 channels in planar lipid bilayers. 4, 7, 38 Chen and colleagues have proposed that RyR2-Ser2030 is an alternative PKA phosphorylation site. 39 However, they reported that recombinant RyR2-S2030D (designed to mimic constitutively PKA phosphorylated RyR2 at the S2030 site) exhibited no increased activity at different cytosolic (cis) Ca 2ϩ concentrations as measured by [ 3 H]ryanodine binding, 39 and we also showed that the RyR2-S2030D mutant channels did not have increased activity, whereas the RyR2-S2808D channels did. 38 In contrast to their earlier report, Chen and colleagues more recently reported that RyR2-Ser2030 does have a role in the PKA mediated regulation of RyR2 function by luminal [Ca 2ϩ ] SR in a heterologous expression system. 40 Characterization of the molecular and cellular mechanisms of catecholamine-dependent modulation of cardiac contractile function remains challenging. Although use of a PKA phosphorylation-deficient RyR2-S2808A model represents an important technique, dissection of the specific role of RyR2-Ser2808 in cardiac inotropic regulation requires appropriate experimental design and data analyses. State-of-the-art experimental systems predict that the amplitude of I Ca and SR Ca 2ϩ load modulate the amount of RyR2 calcium release. 25, 41 Therefore, important aspects to consider in the future study of ␤-adrenergic modulation of cardiomyocyte ECC gain are: (1) functional Cav1.2-RyR2 coupling; and (2) the relationship between RyR2-dependent Ca 2ϩ release and SR Ca 2ϩ load. Moreover, concomitant PKA and CamKII phosphorylation of Cav1.2 and RyR2 may contribute to increased net SR Ca 2ϩ release. 4, 7, 42, 43 Because the current study did not attempt simultaneous measurement of either Ca v 1.2-dependent or SERCA2a-dependent SR Ca 2ϩ load, there are significant limitations to the authors' conclusions. In summary, intracellular regulation of RyR2-dependent Ca 2ϩ release by catecholamines is a complex mechanism underlying acute cardiac stress adaptation, elucidation of which is likely to lead to significantly better understanding of cardiac physiology and HF.
